J.P. Morgan Chase lowered its outlook on the orthopedic implant market, which means the price target for Stryker, Zimmer and Wright Medical Group is also lower, according to a Benzinga report.
J.P. Morgan lowered forecasts for the U.S. and global knee and hip market, which means the third quarter forecasts for these companies is also low. The price target for Stryker decreased from $58 to $49, Zimmer from $63 to $58 and Wright from $21 to $17.
Read the Benzinga report on J.P. Morgan's lowered forecasts.
Read other coverage on orthopedic device companies:
- VertiFlex Sells Silverbolt Product Portfolio to Exatech
- Stryker Acquires Gaymar Industries
- Medtronic Lowers Profit Forecast, Incurs Price Drop
J.P. Morgan lowered forecasts for the U.S. and global knee and hip market, which means the third quarter forecasts for these companies is also low. The price target for Stryker decreased from $58 to $49, Zimmer from $63 to $58 and Wright from $21 to $17.
Read the Benzinga report on J.P. Morgan's lowered forecasts.
Read other coverage on orthopedic device companies:
- VertiFlex Sells Silverbolt Product Portfolio to Exatech
- Stryker Acquires Gaymar Industries
- Medtronic Lowers Profit Forecast, Incurs Price Drop